Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-24
1997-05-20
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514279, 514281, 546 34, 546 35, 546 39, 546 40, 546 43, 546 44, 546 46, 546 72, A61K 3144, C07D45503, C07D47100
Patent
active
056312644
ABSTRACT:
Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment or prevention of neurodegenerative disorders or neurotoxic injuries utilizing them.
REFERENCES:
patent: 4888347 (1989-12-01), Woodruff
Cotman CW and Iversen L.L. (1987). TINS 10(7) 263-272.
Choi DW 1988) Neuron 1, 623-634.
DeHaven-Hudkins Diane L.
Dority, Jr. John A.
Earley William G.
Kumar Virendra
Mallamo John P.
Davis William J.
DuPont Paul E.
Huang Evelyn
Ivy C. Warren
Sanofi Winthrop Inc.
LandOfFree
Substituted 6,11-ethano-6,11-dihydrobenzo[B]quinolizinium salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 6,11-ethano-6,11-dihydrobenzo[B]quinolizinium salts , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 6,11-ethano-6,11-dihydrobenzo[B]quinolizinium salts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724121